Palvella Therapeutics PVLA EPS (Diluted)

EPS (Diluted) at other companies

Relay Therapeutics, Inc.RLAY

-$0.410.0%

Viridian Therapeutics, Inc.VRDN

-$1.15-5.5%

ANI PharmaceuticalsANIP

$1.05+192%

Arcutis Biotherapeutics, Inc.ARQT

$0.11+185%

Zevra Therapeutics, Inc.ZVRA

$0.14-88.4%

Eton Pharmaceuticals, Inc.ETON

$0.05+183%

FAQ

What is Palvella Therapeutics's EPS (diluted)?

Palvella Therapeutics (PVLA) reported EPS (diluted) of -$1.20 in Q1 2026.

How has Palvella Therapeutics's EPS (diluted) changed year-over-year?

Palvella Therapeutics's EPS (diluted) decreased by 62.2% year-over-year, from -$0.74 to -$1.20.

What is the long-term trend for Palvella Therapeutics's EPS (diluted)?

Over 2 years (2021 to 2025), Palvella Therapeutics's EPS (diluted) has grown at a 131.9% compound annual growth rate (CAGR), from -$0.69 to -$3.71.

What does EPS (diluted) mean?

Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.